text.skipToContent text.skipToNavigation
Need help? Please contact us

You searched for "chemically defined%3A%3A%3A%3Arelevance"

67 Products found
Too many choices? Use the filter option on the left to narrow your product listing.
  • AccuGENE™ 1 M Tris HCl Buffer
    AccuGENE™ 1 M Tris HCl Buffer
    AccuGENETM 1M TRIS-HCl Buffer, pH 7.4, 1 L
    Catalog #: 51237
    Sales unit: each
    Compare
    EA
  • MycoZap™ Plus-PR
    MycoZap™ Plus-PR

    Antibiotic formulation for prevention of bacteria, fungi and mycoplasma contaminations in primary cell cultures.

    Catalog #: VZA-2022
    Sales unit: items
    Compare
    ST
  • MycoZap™ Plus-PR
    MycoZap™ Plus-PR
    Antibiotic formulation for prevention of bacteria, fungi and mycoplasma contaminations in primary cell cultures.
    Catalog #: VZA-2021
    Sales unit: items
    Compare
    ST
  • Human Cryo Kupffer Cells, 0.2 Million
    Human Cryo Kupffer Cells, 0.2 Million

    Naïve Kupffer cells derived from human liver tissue. 0.2 million cells per vial

    Catalog #: HLKC-200K
    Sales unit: Ampule
    Compare
    AMP
  • Human Cryo Kupffer Cells, 0.5 Million
    Human Cryo Kupffer Cells, 0.5 Million

    Naïve Kupffer cells derived from human liver tissue. 0.5 million cells per vial.

    Catalog #: HLKC-500K
    Sales unit: Ampule
    Compare
    AMP
  • TheraPEAK<sup class=reg>®</sup> P3 Primary Cell Nucleofector<sup class=reg>®</sup>  Solution Set (22.5 mL + 5 mL)
    TheraPEAK® P3 Primary Cell Nucleofector® Solution Set (22.5 mL + 5 mL)

    For use in combination with TheraPEAK® Nucleocuvette® Cartridges, supporting the use of the 4D-Nucleofector® LV Unit in a GMP environment.

    Catalog #: G4LP3-22500
    Sales unit: items
    Compare
    ST
  • TheraPEAK<sup class=reg>®</sup> P3 Primary Cell Nucleofector<sup class=reg>®</sup> Solution Set (126 mL + 28 mL)
    TheraPEAK® P3 Primary Cell Nucleofector® Solution Set (126 mL + 28 mL)

    For use in combination with TheraPEAK® Nucleocuvette® Cartridges, supporting the use of the 4D-Nucleofector® LV Unit in a GMP environment.

    Catalog #: G4LP3-126000
    Sales unit: items
    Compare
    ST
  • 2
  • 3
  • 4(current)

You searched for "chemically defined%3A%3A%3A%3Arelevance"

361 Documents found
  • A Non-Viral Method for Modifying and Expanding Primary T Cells
    Learn how Lonza’s Cocoon® Platform, 4D-Nucleofector® LV Unit and X-VIVO® 15 Medium are integrated to enable non-viral genetic modification and subsequent expansion of primary T cells in a functionally-closed, automated workflow.
  • Cell Culture in a Chemically Defined Environment
    Learn about benefits of moving to a serum-free and chemically defined T-cell culture process and discover best practices for achieving optimal results in the absence of serum.
  • Instructions - FGM-CD™ Chem. Defined Fibro. Growth Med.
    Instructions for using TheraPEAK™ Chemically Defined Fibroblast Cell Growth Medium
  • eCHO® Basal Medium and eCHO® Feed Product Information
    Chemically defined serum-free CHO medium for fed-batch cell culturing
  • Scientific Poster
    Evaluation of AAV production in insect cells using chemically defined media
  • Instructions – PPiLight™ Inorganic Pyrophosphate Assay Kit
    Instructions for proper use of PPiLight™ Inorganic Pyrophosphate Assay Kit
  • Instructions - HL-1™ Chemically Defined, Serum-free Media
    Detailed instructions how to use HL-1™ Chemically Defined Serum-free Medium
  • Cell Culture in a Chemically Defined Environment - Written Summary
    Learn about the benefits of moving to a serum-free and chemically defined T-cell culture process and discover best practices for achieving optimal results in the absence of serum.
  • Expanded HUVECs for High-throughput Screening
    HUVECs are a good primary endothelial cell type for many in vitro studies and also for several high-throughput screening applications. Consequently, Lonza offers, HUVEC-XL. These cells are expanded to passage-3 from pooled P1-HUVECs and packaged at 10 million cells per ampoule.
  • The Efficiency and Accuracy of Automated Endotoxin Testing and Process Optimization
    Full Title:   Streamlining Your QC Testing: The Efficiency and Accuracy of Automated Endotoxin Testing and Process Optimization
  • A Serum-free Chemically Defined Medium for the Expansion of NHDF-Adult
    Traditionally, in vitro cell culture medium contains animal-derived products like serum, tissue extracts or hydrosylates. They are also a source of undesirable factors, such as endotoxin, and pose potential BSE risks. The undefined and variable nature of these components is a challenge in basic research and applied biomedical sciences. Lonza has developed a serum-free chemically defined, fibroblast growth medium, to propagate primary adult normal human dermal fibroblasts (NHDF).
  • A Novel Chemically Defined Medium Supports Superior Cross-platform T-cell Expansion
    This poster showcases how the chemically defined TheraPEAK® T-VIVO® Medium supports superior T-cell expansion across different platforms.
  • eBook by The Scientist and Lonza: Primary Cells in Research
    An ebook produced in conjunction with The Scientist highlighting Primary Cells, Primary Cell Culture Process, In Vitro, and Relevant In Vitro Models.
  • Validation of Growth Factors for Chemically Defined Manufacturing for Human Mesenchymal Stem Cells
    Scientific Poster Presentation
  • Validation of Cytokines for the Chemically Defined Manufacturing of Human CD34 Positive Hematopoietic Precursor Cells
    Lonza Poster
  • A Novel, Chemically Defined, Serum-Free Cell Culture Medium for Expansion of Transfected T Cells
    In this study, we present data generated with TheraPEAK® T-VIVO®, a novel, chemically defined, non-animal origin cell culture medium utilized to grow T cells in the absence of serum, before and after transfection with the Nucleofector® Technology.
  • Cold Storage of Fresh Leukopak Maintains Cell Viability and Functionality
    Learn how advanced cold storage approaches enable optimal levels of product integrity, quality, stability and viability
  • Primary Human Umbilical Vein Endothelial Cells
    Tech note demonstrating the successful development of tube formation assay using primary HUVECs that can be used to visualize angiogenesis in real-time.
  • The Cell and Gene Therapies Journey from Translation to Commercialization
    Download our comprehensive eBook on how to accelerate cell and gene therapy development, from translation to GMP production and commercialization.
  • TheraPEAK® T-VIVO® Cell Culture Medium – Overview
    View or download this document for a comprehensive overview and learn how the chemically defined TheraPEAK® T-VIVO® Medium enhances T-cell culture and accelerates therapy development.
  • 1(current)
  • 2
  • 3